China SXT Pharmaceuticals, Inc. (SXTC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2024-04-05; 1-for-8, first reflected in a filing dated 2025-07-31. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

679.6K
Year ended 2026-03-31
+173.1%
3-year compound annual growth
20.57M2017-03-31: 20.00M2018-03-31: 20.00M2019-03-31: 20.57M2021-03-31: 719.5K2022-03-31: 41.6K2023-03-31: 33.4K2024-03-31: 7232025-03-31: 9.5K2026-03-31: 679.6K679.6K
2017-03-31 Weighted Average Diluted Shares (shares) 2026-03-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2026-03-31679.6Kn/m2026-07-01, From 2025-04-01
2025-03-319.5Kn/m2026-07-01, From 2024-04-01
2024-03-31723-97.8%2026-07-01, From 2023-04-01
2023-03-3133.4Kn/c2025-07-31, From 2022-04-01
2022-03-3141.6Kn/c2024-08-13, From 2021-04-01
2021-03-31719.5Kn/a2023-07-31, From 2020-04-01
No annual figure between 2019-03-31 and 2021-03-31.
2019-03-3120.57M+2.8%2019-08-15, From 2018-04-01
2018-03-3120.00M0.0%2019-08-15, From 2017-04-01
2017-03-3120.00Mn/a2019-08-15, From 2016-04-01